NCT04447703 2025-12-02
Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study
Thomas Jefferson University
Phase NA Completed
Thomas Jefferson University
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
University of Aberdeen
Maastricht Radiation Oncology
M.D. Anderson Cancer Center
University of Chicago
Institut de Cancérologie de la Loire